Evaluation of procalcitonin and neopterin level in serum of patients with acute bacterial infection

Brazilian Journal of Infectious Diseases

Volumn 14, Issue 3, 2010, Pages 252-255

  Pourakbari, Babak ^b   Mamishi, Setareh ^a,b   Zafari, Javid ^a   Khairkhah, Hanieh ^a   Ashtiani, Mohammad H ^a   Abedini, Masomeh ^c   Afsharpaiman, Shahla ^d   Rad, Soroush Seifi ^e  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Kermanshah University Medical of Sciences   (Iran)

^d BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Neopterin; Procalcitonin; SIRS

Indexed keywords

NEOPTERIN; PROCALCITONIN;

ARTICLE; BACTERIAL INFECTION; CHILD; CLINICAL DECISION MAKING; CONTROLLED STUDY; DIAGNOSTIC VALUE; EMERGENCY WARD; FEMALE; FEVER; HUMAN; INFANT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 77957936883     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1413-86702010000300009     Document Type: Article

References (27)

1. Lacour AG, Zamora SA, Gervaix A. Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center. Pediatrics 2003; 112(5):1054-60.
2. Titus MO, Wright SW. Prevalence of serious bacterial infections in febrile infants with respiratory syncytial virus infection. Pediatrics 2003; 112(2):282-4.
3. Chan YL, Tseng CP, Tsay PK et al. Procalcitonin as a marker of bacterial infection in the emergency department: an observational study. Critical Care 2004; 8(1):12-20.
4. Castelli GP, Pognani C, Meisner M et al. Procalcitonin and C-reactive protein during systemic infl ammatory response syndrome, sepsis and organ dysfunction. Critical Care 2004; 8(4):234-42.
5. Meisner M, Tschaikowsky K, Palmaers T et al. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Critical Care 1999; 3(1):45-50.
6. Muller B, Becker KL, Schachinger H et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000; 28(4):977-83.
7. Gendrel D, Bohuon C. Procalcitonin as a marker of bacterial infection. Pediatr Infect Dis J 2000; 19(8):679-87.
8. Nijsten MW, Oling P, The TH. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 2000; 28:458-61.
9. Whicher J, Bienvenu J, Monneret G. Procalcitonin as an acute phase marker. Ann Clin Biochem 2001; 38(5):483-93.
10. Oberhoffer M, Stonans I, Russwurm S et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med 1999; 134(1):49-55.
11. Sheldon J, Riches PG, Soni N et al. Plasma neopterin as an adjunct to C-reactive protein in assessment of infection. Clin Chem 1991; 37(12):2038-42.
12. Samsonov MY, Nassonov EL, Tilz GP et al. Elevated serum levels of neopterin in adult patients with polymyositis/dermatomyositis. British Journal of Rheumatology 1997; 36(6):656-60.
13. Hamerlinck FFV. Neopterin: a review. Exp Dermatol 1999; 8(3):167-76.
14. Burleson DG, Johnson A, Salin M et al. Identifi cation of neopterin as a potential indicator of infection in burned patients. Proc Soc Exp Biol Med 1992; 199:305-10.
15. Balogh D, Lammer H, Kornberger E et al. Neopterin plasma levels in burn patients. Burns 1992; 18(3):185-8.
16. Ruokonen E, Ilkka L, Niskanen M, Takala J. Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anaesthesiol Scand 2002; 46:398-404.
17. Levine DA, Platt SL, Dayan SP et al. Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus. Infections Pediatrics 2004; 113(3):1728-34.
18. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. The Lancet 1993; 341:515-8.
19. Suprin E, Camus C, Gacouin A et al. Procalcitonin: a valuable indicator of infection in a medical ICU? Intensive Care Med 2000; 26:1232-8.
20. Selberg O, Hecker H, Martin M, Klos A, Bautsch W, Kohl J. Discrimination of sepsis and systemic infl ammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med 2000; 28:2793-8.
21. BalcI C, Sungurtekin H, Gurses E, Kaptanoglu B. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care Med 2003; 7(1):85-90.
22. Mitaka C. Clinical laboratory differentiation of infectious versus non-infectious systemic infl ammatory response syndrome. Clin Chim Acta 2005; 351:17-29.
23. Sakurai A, Goto M. Neopterin: isolation from human urine. J Biochem 1967; 61:142-5.
24. Fuchs D, Hausen A, Huber C et al. Pteridinausscheidung als Marker für alloantigen-induzierte Lymphozytenproliferation. Hoppe Seyler's Z. Physiol Chem 1982; 363:661-4.
25. Hoffmann G, Wirleitner B, Fuchs D. Potential role of immune system activation associated production of neopterin derivatives in humans. Infl ammation Res 2003; 52:313-21.
26. Murr C, Widner B, Wirleitner B, Fuchs D. Neopterin as a marker for immune system activation. Curr Drug Metabol 2002; 3:175-87.
27. Schennach H, Meyersbach P, Schonitzer D, Fuchs D. Additional neopterin screening to improve safety of blood donations. Pteridines 2000; 11:76-80.